CA2490008C - Low water content high refractive index, flexible, polymeric compositions - Google Patents
Low water content high refractive index, flexible, polymeric compositions Download PDFInfo
- Publication number
- CA2490008C CA2490008C CA2490008A CA2490008A CA2490008C CA 2490008 C CA2490008 C CA 2490008C CA 2490008 A CA2490008 A CA 2490008A CA 2490008 A CA2490008 A CA 2490008A CA 2490008 C CA2490008 C CA 2490008C
- Authority
- CA
- Canada
- Prior art keywords
- methacrylate
- polymeric compositions
- percent
- acrylate
- ophthalmic device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/12—Esters of monohydric alcohols or phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
- C08F212/02—Monomers containing only one unsaturated aliphatic radical
- C08F212/04—Monomers containing only one unsaturated aliphatic radical containing one ring
Abstract
Optically transparent, relatively high refractive index polymeric compositions and ophthalmic devices such as intraocular lenses and corneal inlays made therefrom are described herein. The preferred polymeric compositions are produced through the polymerization of one or more copolymers with one or more hydrophilic monomers and optionally one or more aromatic-based monomers, hydrophobic monomers or a combination thereof.
Description
LOW WATER CONTENT, HIGH REFRACTIVE INDEX, FLEXIBLE, POLYMERIC COMPOSITIONS
Field of the Invention:
The present invention relates to polymeric compositions useful in the manufacture of biocompatible medical devices. More particularly, the present invention relates to copolymers capable of polymerization to form polymeric compositions having desirable physical characteristics and refractive indices useful in the manufacture of ophthalmic devices.
Background of the Invention:
Since the 1940's ophthalmic devices in the form of intraocular lens (IOL) implants have been utilized as replacements for diseased or damaged natural ocular lenses. In most cases, an intraocular lens is implanted within an eye at the time of surgically removing the diseased or damaged natural lens, such as for example, in the case of cataracts. For decades, the preferred material for fabricating such intraocular lens implants was poly(methyl methacrylate), which is a rigid, glassy polymer.
Softer, more flexible IOL implants have gained in popularity in more recent years due to their ability to be compressed, folded, rolled or otherwise deformed. Such softer IOL implants may be deformed prior to insertion thereof through an incision in the cornea of an eye. Following insertion of the IOL in an eye, the IOL returns to its original pre-deformed shape due to the memory characteristics of the soft material. Softer, more flexible IOL
implants as just described may be implanted into an eye through an incision that is much smaller, i.e., less than 4.0 mm, than that necessary for more rigid IOLs, i.e., 5.5 to 7.0 mm. A larger incision is necessary for more rigid IOL implants because the lens must be inserted through an incision in the cornea slightly larger than the diameter of the inflexible IOL optic portion.
Accordingly, more rigid IOL implants have become less popular in the market since larger incisions have been found to be associated with an increased incidence of postoperative complications, such as induced astigmatism.
With recent advances in small-incision cataract surgery, increased emphasis has been placed on developing soft, foldable materials suitable for use in artificial IOL implants. In general, the materials of current commercial IOLs fall into one of three general categories: silicones, hydrophilic acrylics and hydrophobic acrylics.
Field of the Invention:
The present invention relates to polymeric compositions useful in the manufacture of biocompatible medical devices. More particularly, the present invention relates to copolymers capable of polymerization to form polymeric compositions having desirable physical characteristics and refractive indices useful in the manufacture of ophthalmic devices.
Background of the Invention:
Since the 1940's ophthalmic devices in the form of intraocular lens (IOL) implants have been utilized as replacements for diseased or damaged natural ocular lenses. In most cases, an intraocular lens is implanted within an eye at the time of surgically removing the diseased or damaged natural lens, such as for example, in the case of cataracts. For decades, the preferred material for fabricating such intraocular lens implants was poly(methyl methacrylate), which is a rigid, glassy polymer.
Softer, more flexible IOL implants have gained in popularity in more recent years due to their ability to be compressed, folded, rolled or otherwise deformed. Such softer IOL implants may be deformed prior to insertion thereof through an incision in the cornea of an eye. Following insertion of the IOL in an eye, the IOL returns to its original pre-deformed shape due to the memory characteristics of the soft material. Softer, more flexible IOL
implants as just described may be implanted into an eye through an incision that is much smaller, i.e., less than 4.0 mm, than that necessary for more rigid IOLs, i.e., 5.5 to 7.0 mm. A larger incision is necessary for more rigid IOL implants because the lens must be inserted through an incision in the cornea slightly larger than the diameter of the inflexible IOL optic portion.
Accordingly, more rigid IOL implants have become less popular in the market since larger incisions have been found to be associated with an increased incidence of postoperative complications, such as induced astigmatism.
With recent advances in small-incision cataract surgery, increased emphasis has been placed on developing soft, foldable materials suitable for use in artificial IOL implants. In general, the materials of current commercial IOLs fall into one of three general categories: silicones, hydrophilic acrylics and hydrophobic acrylics.
In general, high water content hydrophilic acrylics, or "hydrogels,"
have relatively low refractive indices, making them less desirable than other materials with respect to minimal incision size. Low refractive index materials require a thicker IOL optic portion to achieve a given refractive power. Silicone materials may have a higher refractive index than high-water content hydrogels, but tend to unfold explosively after being placed in the eye in a folded position. Explosive unfolding can potentially damage the corneal endothelium and/or rupture the natural lens capsule and associated zonules. Low glass transition temperature hydrophobic acrylic materials are desirable because they typically have a high refractive index and unfold more slowly and more controllably than silicone materials. Unfortunately, low glass transition temperature hydrophobic acrylic materials, which contain little or no water initially, may absorb pockets of water in vivo causing light reflections or "glistenings." Furthermore, it may be difficult to achieve ideal folding and unfolding characteristics due to the temperature sensitivity of some acrylic polymers.
Because of the noted shortcomings of current polymeric materials available for use in the manufacture of ophthalmic implants, there is a need for stable, biocompatible polymeric materials having desirable physical characteristics and refractive indices.
have relatively low refractive indices, making them less desirable than other materials with respect to minimal incision size. Low refractive index materials require a thicker IOL optic portion to achieve a given refractive power. Silicone materials may have a higher refractive index than high-water content hydrogels, but tend to unfold explosively after being placed in the eye in a folded position. Explosive unfolding can potentially damage the corneal endothelium and/or rupture the natural lens capsule and associated zonules. Low glass transition temperature hydrophobic acrylic materials are desirable because they typically have a high refractive index and unfold more slowly and more controllably than silicone materials. Unfortunately, low glass transition temperature hydrophobic acrylic materials, which contain little or no water initially, may absorb pockets of water in vivo causing light reflections or "glistenings." Furthermore, it may be difficult to achieve ideal folding and unfolding characteristics due to the temperature sensitivity of some acrylic polymers.
Because of the noted shortcomings of current polymeric materials available for use in the manufacture of ophthalmic implants, there is a need for stable, biocompatible polymeric materials having desirable physical characteristics and refractive indices.
Summary of the Invention:
Soft, foldable, high refractive index, high elongation polymeric compositions of the present invention having a water content greater than 4.5 percent to avoid water vacoule formations or "glistenings" in vivo are produced through the polymerization of one or more copolymers with one or more hydrophilic monomers. Such suitable copolymers are produced by combining two or more CI-1o alkyl methacrylate, Cl-lo alkyl acrylate, C6-40 arylalkyl acrylate, or C6-4o arylalkyl methacrylate monomers. The polymeric compositions produced from such copolymers and hydrophilic monomer(s) have ideal physical properties for the manufacture of ophthalmic devices.
The polymeric compositions of the present invention are transparent, flexible, of relatively high strength for durability during surgical manipulations, of relatively high elongation, of relatively high refractive index and are biocompatible. The subject polymeric compositions are particularly well suited for use as intraocular lens (IOLs) implants, contact lenses, keratoprostheses, corneal rings, corneal inlays and the like.
Accordingly, it is an object of the present invention to provide transparent, flexible, polymeric compositions having desirable physical characteristics for the manufacture of ophthalmic devices.
Another object of the present invention is to provide polymeric compositions of relatively high refractive index.
Another object of the present invention is to provide polymeric compositions suitable for use in the manufacture of intraocular lens implants.
Another object of the present invention is to provide polymeric compositions that are biocompatible.
Another object of the present invention is to provide polymeric compositions are flexible with desirable memory properties.
Still another object of the present invention is to provide polymeric compositions that are economical to produce.
These and other objectives and advantages of the present invention, some of which are specifically described and others that are not, will become apparent from the detailed description and claims that follow.
Detailed Description of the Invention:
The present invention relates to copolymers useful in the production of biocompatible polymeric compositions having a water content greater than 4.5 percent by weight to avoid water vacoule formation in vivo. Current commercial acrylic-based ophthalmic products having a water content less than 4.5 percent by weight have been known to trap water to form water vacoules or "glistenings" in vivo. The subject polymeric compositions having a higher water content greater than 4.5 percent by weight avoids problems related to water vacoule formation while achieving particularly desirable physical properties. The subject polymeric compositions have a relatively high refractive index of approximately 1.45 or greater and relatively high elongation of approximately 80 percent or greater. Accordingly, the subject polymeric compositions are ideal for use in the manufacture of ophthalmic devices.
Suitable copolymers for use in the production of the subject polymeric compositions are produced by combining two or more monomers selected from the group consisting of C1-10 alkyl methacrylate such as for example but not limited to methyl methacrylate, butyl methacrylate or octyl methacrylate but preferably methyl methacrylate to control mechanical properties, C1-10 alkyl acrylate such as for example ethyl acrylate, propyl acrylate or hexyl acrylate put preferably ethyl acrylate to control mechanical properties, C6-40 arylalkyl acrylate such as for example but not limited to phenylpropyl acrylate or phenylbutyl acrylate but preferably phenylpropyl acrylate to increase refractive index, and C6-40 arylalkyl methacrylate such as for example but not limited to phenylethyl methacrylate, phenylpentyl methacrylate or phenyloctyl methacrylate but preferably phenylethyl methacrylate to increase refractive index.
Examples of hydrophilic monomers useful for polymerization with one or more copolymers of the present invention include for example but are not limited to N,N-dimethylacrylamide, glycerol methacrylate, N-vinylpyrrolidinone and 2-hydroxyethyl methacrylate but preferably N,N-dimethylacrylamide for increased hydrophilicity.
One or more copolymers of the present invention along with one or more hydrophilic monomers may be polymerized alone or with one or more aromatic-based monomers, hydrophobic monomers or a combination thereof to produce polymeric compositions of the present invention.
Examples of aromatic-based monomers useful for polymerization with one or more copolymers and hydrophilic monomer(s) of the present invention include for example but are not limited to 2-phenyoxyethyl methacrylate, 3,3-diphenylpropyl methacrylate, 2-phenyloxyethyl methacrylate, 3-methacryloyloxypropyldiphenylmethylsilane, 2-(1-naphthylethyl) methacrylate, 3-phenylpropyl acrylate and 2-(2-naphthylethyl) methacrylate but preferably 2-(1-naphthylethyl) methacrylate for increased refractive index.
Examples of hydrophobic monomers useful for polymerization with one or more copolymers and hydrophilic monomer(s) of the present invention include for example but are not limited to 2-ethylhexyl methacrylate and methyl methacrylate and but preferably 2-ethylhexyl methacrylate for increased refractive index.
[0021] Polymeric compositions of the present invention are produced through free radical polymerization as illustrated below in Scheme 1.
'Y I
0 + ~CH3 + N, n y z (n, y and z represent the same or different natural numbers) Scheme 1 The physical and mechanical properties of polymeric compositions produced from formulations based on the polymerization of the copolymer PPA/DMA/APDMS or (3-phenylpropyl acrylate-co-N,N-dimethylacrylamide-co-3-acryloyloxypropyldiphenylmethylsilane) are set forth below in Table 1.
TABLE I
Mechanical and Physical Property Results of formulations based on copolymer PPA/DMA/APDMS
Composition W/W % R.I. Mod Tear % Elong. % %
(g/mm2) (g/mm) Rec. H20 PPA/DMA/APDMS/ 75/25/0/20/1 1.5349 5.1 hexanol/Eg* **
75/25/0/20/2 1.5364 55 24 197 88 6.5 75/25/0/20/3 86 5.0 65/25/10/20/1 1.5396 50 47 338 80 4.5 65/25/10/20/2 1.5442 81 54 228 77 5 65/25/10/2013 1.5448 143 57 178 72 5.7 55/25/20/20/1 1.5409 94 79 332 70 5.5 55/25/20/20/2 1.5429 141 77 232 64 4.8 55/25/20/20/3 1.5422 196 83 184 60 5 *Eg = crosslinker ethyleneglycol dimethacrylate ** All formulations contain 0.5 percent by weight IrgacureTM 819 (Ciba-Geigy, Basel, Switzerland) and no UV blocker The physical and mechanical properties of polymeric compositions of the present invention produced from formulations based on the copolymer PPA/DMA/MMA or (3-phenyipropyl acrylate-co-N,N-dimethylacrylamide-co-methyl methacrylate) are set forth below in Table 2.
Mechanical and Physical Property Results of formulations based on the copolymer PPAIMMAIDMA
Composition W/W % R.I. Mod Tear % Elong. % %
(g/mm2) (g/mm) Rec. H20 PPA/MMA/DMA* 65/30/35 1.5108 290 127 254 30 11.3 65/0/35 1.5252 81 16 89 95 6.7 6510/35 1.5164 93 36 137 88 10.1 6520/35 1.517 161 72 183 64 10.5 * Crosslinker ethyleneglycol dimethacrylate at 3.0%, initiator lrgacureTM 819 at 0.5% and no UV blocker Low water content of greater than 4.5 percent but less than 15 percent water content by volume and high water content "hydrogels" of 15 percent or higher water content by volume polymeric compositions of the present invention having ideal physical characteristics for use in the manufacture of ophthalmic devices are described herein. In the production of such polymeric compositions of the present invention, one or more copolymers of the present invention are polymerized with one or more hydrophilic monomers to form crosslinked three-dimensional networks.
However, one or more crosslinking agents may optionally be added in quantities less than 10 percent weight per volume (WN) to the copolymers if desired prior to polymerization.
Examples of suitable crosslinking agents include but are not limited to diacrylates and dimethacrylates of triethylene glycol, butylene glycol, neopentyl glycol, hexane-1,6-diol, thio-diethylene glycol and ethylene glycol, trimethylolpropane triacrylate, N,N'-dihydroxyethylene bisacrylamide, diallyl phthalate, triallyl cyanurate, divinylbenzene; ethylene glycol divinyl ether, N,N-methylene-bis-(meth)acrylamide, sulfonated divinylbenzene and divinylsulfone.
Although not required, copolymers within the scope of the present invention may optionally have one or more strengthening agents added prior to polymerization preferably in quantities of less than about 80 weight percent but more typically from about 20 to about 60 weight percent.
Examples of suitable strengthening agents are described in U.S.
Patent Nos. 4,327,203, 4,355,147 and 5,270,418.
Specific examples, not intended to be limiting, of such strengthening agents include cycloalkyl acrylates and methacrylates, such as for example tert-butylcyclohexyl methacrylate and isopropylcyclopentyl acrylate.
One or more ultraviolet light absorbers may optionally be added to the copolymers prior to polymerization in quantities typically less than 2 percent WN. Suitable ultraviolet light absorbers for use in the present invention include for example but are not limited to (3-(4-benzotriazoyl-3-hydroxyphenoxy)ethyl acrylate, 4-(2-acryloxyethoxy)-2-hydroxybenzophenone, 4-methacryloyloxy-2-hydroxybenzophenone, 2-(2'-methacryloyloxy-5'-methylphenyl)benzotr.iazole, 2-(2'-hydroxy-5'-methacryoxyethylphenyl)-2H-benzotriazole, 2-[3'-tert-butyl-2'-hydroxy-5'-(3"-methacryloyloxypropyf)phenyl]-5-chlorobenzotriazole, 2-(3'-tert-butyl-5'-(3"-dimethylvinylsilylpropoxy)-2'-hydroxyphenyl]-5-methoxybenzotriazole, 2-(3'-allyl-2'-hydroxy-5'-methylphenyl)benzotriazole, 2-[3'-tert-butyl-2'-hyd roxy-5'-(3"-methacryloyloxypropoxy)phenyl]-5-methoxybenzotriazole, and 2-[3'-tert-butyl-2'-hydroxy-5'-(3"-methacyloyloxypropoxy)phenyl]-5-chlorobenzotriazole wherein 0-(4-benzotriazoyl-3-hydroxyphenoxy)ethyl acrylate is the preferred ultraviolet light absorber.
One or more suitable free radical thermal polymerization initiators may be added to the copolymers of the present invention. Examples of such initiators include but are not limited to organic peroxides, such as acetyl peroxide, lauroyl peroxide, decanoyl peroxide, stearoyl peroxide, benzoyl peroxide, tert-butyl peroxypivalate, peroxydicarbonate, and the like.
Preferably such an initiator is employed in a concentration of approximately 0.01 to 1 percent by weight of the total monomer mixture.
Representative ultraviolet light (UV) initiators include those known in the field such as for example but not limited to benzoin methyl ether, benzoin ethyl ether, DarocurT"' 1173, 1164, 2273, 1116, 2959, 3331 (EM Industries) and IrgacurTM 651 and 184 (Ciba-Geigy, Basel, Switzerland).
The polymeric compositions of the present invention are transparent, flexible, of relatively high refractive index and of relatively high elongation.
The polymeric compositions of the present invention with the desirable physical properties noted above are particularly useful in the manufacture of ophthalmic devices such as but not limited to relatively thin, foldable intraocular lens implants, contact lenses and corneal inlays.
IOLs having relatively thin optic portions are critical in enabling a surgeon to minimize surgical incision size. Keeping the surgical incision size to a minimum reduces intraoperative trauma and postoperative complications. A relatively thin IOL optic portion is also critical for accommodating certain anatomical locations in the eye such as the anterior chamber and the ciliary suicus. IOLs may be placed in the anterior chamber for increasing visual acuity in either aphakic or phakic eyes, or placed in the ciliary suicus for increasing visual acuity in phakic eyes.
The polymeric compositions of the present invention have the flexibility required to allow implants manufactured from the same to be folded or deformed for insertion into an eye through the smallest possible surgical incision, i.e., 3.5 mm or smaller. It is unexpected that the subject polymeric compositions could possess the ideal physical properties described herein.
The ideal physical properties of the subject polymeric compositions are unexpected because high refractive index copolymers typically lend to polymers that have increased crystallinity and decreased clarity, which does not hold true in the case of the subject polymeric compositions. The higher water content of greater than 4.5 percent by weight likewise reduces or eliminates water vacoule formation in vivo.
The subject copolymers and polymeric compositions produced therefrom are described in still greater detail in the examples that follow.
EXAMPLE 1:
A film was cast using 65 parts phenylpropyl acrylate, 25 parts dimethylacrylamide, 10 parts methacryloyloxypropyl diphenylmethylsilane, 3 parts ethylene glycol dimethacrylate and 0.5 percent by weight IrgacureT""
819 photoinitiator. The cure conditions consisted of a two-hour ultraviolet irradiation. The films were then extracted in isopropanol for 24 hours, air dried and then hydrated in a borate buffered saline. The resultant films possessed a modulus of 143 g/mm2, a tear strength of 57 g/mm and a water content of 5.7 percent by weight.
EXAMPLE 2:
A film was cast using 65 parts phenylpropyl acrylate, 30 parts methyl methacrylate, 35 parts dimethylacrylamide, 3 parts ethylene glycol dimethacrylate and 0.5 percent by weight Irgacure 819 photoinitiator. The cure conditions consisted of a two-hour ultraviolet irradiation. The films were extracted in isopropanol for 24 hours, air dried and then hydrated in a borate buffered saline. The resultant films possessed a modulus of 290 g/mm2, a tear strength of 127 g/mm and a water content of 11.3 percent by weight.
The film was clear and showed no visible water vacoules after two months at 37 Celsius.
EXAMPLE 3:
A film was cast using 65 parts phenylpropyl acrylate, 30 parts methyl methacrylate, 35 parts dimethylacrylamide, 3 parts ethylene glycol dimethacrylate and 0.5 percent by weight Irgacure 819 photoinitiator. The cure conditions consisted of a two-hour ultraviolet irradiation. The films were extracted in isopropanol for 24 hours, air dried and then hydrated in a borate buffered saline. The resultant films possessed a modulus of 761 g/mm2, a tear strength of 340 g/mm and a water content of 3.7 percent by weight. The film was initially transparent following hydration, yet showed water vacuoles after two months at 370 Celsius.
Ophthalmic devices such as but not limited to IOLs manufactured using the polymeric compositions of the present invention can be of any design capable of being rolled or folded for implantation through a relatively small surgical incision, i.e., 3.5 mm or less. For example, ophthalmic devices such as IOLs typically comprise an optic portion and one or more haptic portions. The optic portion reflects light onto the retina and the permanently attached haptic portions hold the optic portion in proper alignment within an eye. The haptic portions may be integrally formed with the optic portion in a one-piece design or attached by staking, adhesives or other methods known to those skilled in the art in a multipiece design.
The subject ophthalmic devices, such as for example IOLs, may be manufactured to have an optic portion and haptic portions made of the same or differing materials. Preferably, in accordance with the present invention, both the optic portion and the haptic portions of the IOLs are made of one or more polymeric compositions of the present invention. Alternatively however, the IOL optic portion and haptic portions may be manufactured from differing materials and/or differing polymeric compositions of the present invention, such as described in U.S. Patent Numbers 5, 217,491 and 5,326,506. Once the particular material or materials are selected, the same is either cast in molds of the desired shape or cast in the form of rods and lathed or machined into disks. If cast in the form of rods and lathed or machined into disks, the disks are lathed or machined into IOLs at low temperatures below the glass transition temperature(s) of the material(s). The IOLs, whether molded or machined/lathed, are then cleaned, polished, packaged and sterilized by customary methods known to those skilled in the art.
In addition to IOLs, the polymeric compositions of the present invention are also suitable for use in the manufacture of other ophthalmic devices such as but not limited to contact lenses, keratoprostheses, capsular bag extension rings, corneal inlays, corneal rings or like devices.
IOLs manufactured using the unique polymeric compositions of the present invention are used as customary in the field of ophthalmology. For example, in a surgical procedure, an incision is placed in the cornea of an eye. Most commonly, through the corneal incision the natural lens of the eye is removed (aphakic application) such as in the case of a cataractous natural lens. An IOL is then inserted into the anterior chamber, posterior chamber or lens capsule of the eye prior to closing the incision. However, the subject ophthalmic devices may be used in accordance with other surgical procedures known to those skilled in the field of ophthalmology.
While there is shown and described herein copolymers, polymeric compositions, methods of producing the copolymers and polymeric compositions, methods of producing ophthalmic devices using the polymeric compositions and methods of using ophthalmic devices manufactured from the polymeric compositions, all in accordance with the present invention, it will be manifest to those skilled in the art that various modifications may be made without departing from the spirit and scope of the underlying inventive concept. The present invention is likewise not intended to be limited to particular devices described herein except insofar as indicated by the scope of the appended claims.
Soft, foldable, high refractive index, high elongation polymeric compositions of the present invention having a water content greater than 4.5 percent to avoid water vacoule formations or "glistenings" in vivo are produced through the polymerization of one or more copolymers with one or more hydrophilic monomers. Such suitable copolymers are produced by combining two or more CI-1o alkyl methacrylate, Cl-lo alkyl acrylate, C6-40 arylalkyl acrylate, or C6-4o arylalkyl methacrylate monomers. The polymeric compositions produced from such copolymers and hydrophilic monomer(s) have ideal physical properties for the manufacture of ophthalmic devices.
The polymeric compositions of the present invention are transparent, flexible, of relatively high strength for durability during surgical manipulations, of relatively high elongation, of relatively high refractive index and are biocompatible. The subject polymeric compositions are particularly well suited for use as intraocular lens (IOLs) implants, contact lenses, keratoprostheses, corneal rings, corneal inlays and the like.
Accordingly, it is an object of the present invention to provide transparent, flexible, polymeric compositions having desirable physical characteristics for the manufacture of ophthalmic devices.
Another object of the present invention is to provide polymeric compositions of relatively high refractive index.
Another object of the present invention is to provide polymeric compositions suitable for use in the manufacture of intraocular lens implants.
Another object of the present invention is to provide polymeric compositions that are biocompatible.
Another object of the present invention is to provide polymeric compositions are flexible with desirable memory properties.
Still another object of the present invention is to provide polymeric compositions that are economical to produce.
These and other objectives and advantages of the present invention, some of which are specifically described and others that are not, will become apparent from the detailed description and claims that follow.
Detailed Description of the Invention:
The present invention relates to copolymers useful in the production of biocompatible polymeric compositions having a water content greater than 4.5 percent by weight to avoid water vacoule formation in vivo. Current commercial acrylic-based ophthalmic products having a water content less than 4.5 percent by weight have been known to trap water to form water vacoules or "glistenings" in vivo. The subject polymeric compositions having a higher water content greater than 4.5 percent by weight avoids problems related to water vacoule formation while achieving particularly desirable physical properties. The subject polymeric compositions have a relatively high refractive index of approximately 1.45 or greater and relatively high elongation of approximately 80 percent or greater. Accordingly, the subject polymeric compositions are ideal for use in the manufacture of ophthalmic devices.
Suitable copolymers for use in the production of the subject polymeric compositions are produced by combining two or more monomers selected from the group consisting of C1-10 alkyl methacrylate such as for example but not limited to methyl methacrylate, butyl methacrylate or octyl methacrylate but preferably methyl methacrylate to control mechanical properties, C1-10 alkyl acrylate such as for example ethyl acrylate, propyl acrylate or hexyl acrylate put preferably ethyl acrylate to control mechanical properties, C6-40 arylalkyl acrylate such as for example but not limited to phenylpropyl acrylate or phenylbutyl acrylate but preferably phenylpropyl acrylate to increase refractive index, and C6-40 arylalkyl methacrylate such as for example but not limited to phenylethyl methacrylate, phenylpentyl methacrylate or phenyloctyl methacrylate but preferably phenylethyl methacrylate to increase refractive index.
Examples of hydrophilic monomers useful for polymerization with one or more copolymers of the present invention include for example but are not limited to N,N-dimethylacrylamide, glycerol methacrylate, N-vinylpyrrolidinone and 2-hydroxyethyl methacrylate but preferably N,N-dimethylacrylamide for increased hydrophilicity.
One or more copolymers of the present invention along with one or more hydrophilic monomers may be polymerized alone or with one or more aromatic-based monomers, hydrophobic monomers or a combination thereof to produce polymeric compositions of the present invention.
Examples of aromatic-based monomers useful for polymerization with one or more copolymers and hydrophilic monomer(s) of the present invention include for example but are not limited to 2-phenyoxyethyl methacrylate, 3,3-diphenylpropyl methacrylate, 2-phenyloxyethyl methacrylate, 3-methacryloyloxypropyldiphenylmethylsilane, 2-(1-naphthylethyl) methacrylate, 3-phenylpropyl acrylate and 2-(2-naphthylethyl) methacrylate but preferably 2-(1-naphthylethyl) methacrylate for increased refractive index.
Examples of hydrophobic monomers useful for polymerization with one or more copolymers and hydrophilic monomer(s) of the present invention include for example but are not limited to 2-ethylhexyl methacrylate and methyl methacrylate and but preferably 2-ethylhexyl methacrylate for increased refractive index.
[0021] Polymeric compositions of the present invention are produced through free radical polymerization as illustrated below in Scheme 1.
'Y I
0 + ~CH3 + N, n y z (n, y and z represent the same or different natural numbers) Scheme 1 The physical and mechanical properties of polymeric compositions produced from formulations based on the polymerization of the copolymer PPA/DMA/APDMS or (3-phenylpropyl acrylate-co-N,N-dimethylacrylamide-co-3-acryloyloxypropyldiphenylmethylsilane) are set forth below in Table 1.
TABLE I
Mechanical and Physical Property Results of formulations based on copolymer PPA/DMA/APDMS
Composition W/W % R.I. Mod Tear % Elong. % %
(g/mm2) (g/mm) Rec. H20 PPA/DMA/APDMS/ 75/25/0/20/1 1.5349 5.1 hexanol/Eg* **
75/25/0/20/2 1.5364 55 24 197 88 6.5 75/25/0/20/3 86 5.0 65/25/10/20/1 1.5396 50 47 338 80 4.5 65/25/10/20/2 1.5442 81 54 228 77 5 65/25/10/2013 1.5448 143 57 178 72 5.7 55/25/20/20/1 1.5409 94 79 332 70 5.5 55/25/20/20/2 1.5429 141 77 232 64 4.8 55/25/20/20/3 1.5422 196 83 184 60 5 *Eg = crosslinker ethyleneglycol dimethacrylate ** All formulations contain 0.5 percent by weight IrgacureTM 819 (Ciba-Geigy, Basel, Switzerland) and no UV blocker The physical and mechanical properties of polymeric compositions of the present invention produced from formulations based on the copolymer PPA/DMA/MMA or (3-phenyipropyl acrylate-co-N,N-dimethylacrylamide-co-methyl methacrylate) are set forth below in Table 2.
Mechanical and Physical Property Results of formulations based on the copolymer PPAIMMAIDMA
Composition W/W % R.I. Mod Tear % Elong. % %
(g/mm2) (g/mm) Rec. H20 PPA/MMA/DMA* 65/30/35 1.5108 290 127 254 30 11.3 65/0/35 1.5252 81 16 89 95 6.7 6510/35 1.5164 93 36 137 88 10.1 6520/35 1.517 161 72 183 64 10.5 * Crosslinker ethyleneglycol dimethacrylate at 3.0%, initiator lrgacureTM 819 at 0.5% and no UV blocker Low water content of greater than 4.5 percent but less than 15 percent water content by volume and high water content "hydrogels" of 15 percent or higher water content by volume polymeric compositions of the present invention having ideal physical characteristics for use in the manufacture of ophthalmic devices are described herein. In the production of such polymeric compositions of the present invention, one or more copolymers of the present invention are polymerized with one or more hydrophilic monomers to form crosslinked three-dimensional networks.
However, one or more crosslinking agents may optionally be added in quantities less than 10 percent weight per volume (WN) to the copolymers if desired prior to polymerization.
Examples of suitable crosslinking agents include but are not limited to diacrylates and dimethacrylates of triethylene glycol, butylene glycol, neopentyl glycol, hexane-1,6-diol, thio-diethylene glycol and ethylene glycol, trimethylolpropane triacrylate, N,N'-dihydroxyethylene bisacrylamide, diallyl phthalate, triallyl cyanurate, divinylbenzene; ethylene glycol divinyl ether, N,N-methylene-bis-(meth)acrylamide, sulfonated divinylbenzene and divinylsulfone.
Although not required, copolymers within the scope of the present invention may optionally have one or more strengthening agents added prior to polymerization preferably in quantities of less than about 80 weight percent but more typically from about 20 to about 60 weight percent.
Examples of suitable strengthening agents are described in U.S.
Patent Nos. 4,327,203, 4,355,147 and 5,270,418.
Specific examples, not intended to be limiting, of such strengthening agents include cycloalkyl acrylates and methacrylates, such as for example tert-butylcyclohexyl methacrylate and isopropylcyclopentyl acrylate.
One or more ultraviolet light absorbers may optionally be added to the copolymers prior to polymerization in quantities typically less than 2 percent WN. Suitable ultraviolet light absorbers for use in the present invention include for example but are not limited to (3-(4-benzotriazoyl-3-hydroxyphenoxy)ethyl acrylate, 4-(2-acryloxyethoxy)-2-hydroxybenzophenone, 4-methacryloyloxy-2-hydroxybenzophenone, 2-(2'-methacryloyloxy-5'-methylphenyl)benzotr.iazole, 2-(2'-hydroxy-5'-methacryoxyethylphenyl)-2H-benzotriazole, 2-[3'-tert-butyl-2'-hydroxy-5'-(3"-methacryloyloxypropyf)phenyl]-5-chlorobenzotriazole, 2-(3'-tert-butyl-5'-(3"-dimethylvinylsilylpropoxy)-2'-hydroxyphenyl]-5-methoxybenzotriazole, 2-(3'-allyl-2'-hydroxy-5'-methylphenyl)benzotriazole, 2-[3'-tert-butyl-2'-hyd roxy-5'-(3"-methacryloyloxypropoxy)phenyl]-5-methoxybenzotriazole, and 2-[3'-tert-butyl-2'-hydroxy-5'-(3"-methacyloyloxypropoxy)phenyl]-5-chlorobenzotriazole wherein 0-(4-benzotriazoyl-3-hydroxyphenoxy)ethyl acrylate is the preferred ultraviolet light absorber.
One or more suitable free radical thermal polymerization initiators may be added to the copolymers of the present invention. Examples of such initiators include but are not limited to organic peroxides, such as acetyl peroxide, lauroyl peroxide, decanoyl peroxide, stearoyl peroxide, benzoyl peroxide, tert-butyl peroxypivalate, peroxydicarbonate, and the like.
Preferably such an initiator is employed in a concentration of approximately 0.01 to 1 percent by weight of the total monomer mixture.
Representative ultraviolet light (UV) initiators include those known in the field such as for example but not limited to benzoin methyl ether, benzoin ethyl ether, DarocurT"' 1173, 1164, 2273, 1116, 2959, 3331 (EM Industries) and IrgacurTM 651 and 184 (Ciba-Geigy, Basel, Switzerland).
The polymeric compositions of the present invention are transparent, flexible, of relatively high refractive index and of relatively high elongation.
The polymeric compositions of the present invention with the desirable physical properties noted above are particularly useful in the manufacture of ophthalmic devices such as but not limited to relatively thin, foldable intraocular lens implants, contact lenses and corneal inlays.
IOLs having relatively thin optic portions are critical in enabling a surgeon to minimize surgical incision size. Keeping the surgical incision size to a minimum reduces intraoperative trauma and postoperative complications. A relatively thin IOL optic portion is also critical for accommodating certain anatomical locations in the eye such as the anterior chamber and the ciliary suicus. IOLs may be placed in the anterior chamber for increasing visual acuity in either aphakic or phakic eyes, or placed in the ciliary suicus for increasing visual acuity in phakic eyes.
The polymeric compositions of the present invention have the flexibility required to allow implants manufactured from the same to be folded or deformed for insertion into an eye through the smallest possible surgical incision, i.e., 3.5 mm or smaller. It is unexpected that the subject polymeric compositions could possess the ideal physical properties described herein.
The ideal physical properties of the subject polymeric compositions are unexpected because high refractive index copolymers typically lend to polymers that have increased crystallinity and decreased clarity, which does not hold true in the case of the subject polymeric compositions. The higher water content of greater than 4.5 percent by weight likewise reduces or eliminates water vacoule formation in vivo.
The subject copolymers and polymeric compositions produced therefrom are described in still greater detail in the examples that follow.
EXAMPLE 1:
A film was cast using 65 parts phenylpropyl acrylate, 25 parts dimethylacrylamide, 10 parts methacryloyloxypropyl diphenylmethylsilane, 3 parts ethylene glycol dimethacrylate and 0.5 percent by weight IrgacureT""
819 photoinitiator. The cure conditions consisted of a two-hour ultraviolet irradiation. The films were then extracted in isopropanol for 24 hours, air dried and then hydrated in a borate buffered saline. The resultant films possessed a modulus of 143 g/mm2, a tear strength of 57 g/mm and a water content of 5.7 percent by weight.
EXAMPLE 2:
A film was cast using 65 parts phenylpropyl acrylate, 30 parts methyl methacrylate, 35 parts dimethylacrylamide, 3 parts ethylene glycol dimethacrylate and 0.5 percent by weight Irgacure 819 photoinitiator. The cure conditions consisted of a two-hour ultraviolet irradiation. The films were extracted in isopropanol for 24 hours, air dried and then hydrated in a borate buffered saline. The resultant films possessed a modulus of 290 g/mm2, a tear strength of 127 g/mm and a water content of 11.3 percent by weight.
The film was clear and showed no visible water vacoules after two months at 37 Celsius.
EXAMPLE 3:
A film was cast using 65 parts phenylpropyl acrylate, 30 parts methyl methacrylate, 35 parts dimethylacrylamide, 3 parts ethylene glycol dimethacrylate and 0.5 percent by weight Irgacure 819 photoinitiator. The cure conditions consisted of a two-hour ultraviolet irradiation. The films were extracted in isopropanol for 24 hours, air dried and then hydrated in a borate buffered saline. The resultant films possessed a modulus of 761 g/mm2, a tear strength of 340 g/mm and a water content of 3.7 percent by weight. The film was initially transparent following hydration, yet showed water vacuoles after two months at 370 Celsius.
Ophthalmic devices such as but not limited to IOLs manufactured using the polymeric compositions of the present invention can be of any design capable of being rolled or folded for implantation through a relatively small surgical incision, i.e., 3.5 mm or less. For example, ophthalmic devices such as IOLs typically comprise an optic portion and one or more haptic portions. The optic portion reflects light onto the retina and the permanently attached haptic portions hold the optic portion in proper alignment within an eye. The haptic portions may be integrally formed with the optic portion in a one-piece design or attached by staking, adhesives or other methods known to those skilled in the art in a multipiece design.
The subject ophthalmic devices, such as for example IOLs, may be manufactured to have an optic portion and haptic portions made of the same or differing materials. Preferably, in accordance with the present invention, both the optic portion and the haptic portions of the IOLs are made of one or more polymeric compositions of the present invention. Alternatively however, the IOL optic portion and haptic portions may be manufactured from differing materials and/or differing polymeric compositions of the present invention, such as described in U.S. Patent Numbers 5, 217,491 and 5,326,506. Once the particular material or materials are selected, the same is either cast in molds of the desired shape or cast in the form of rods and lathed or machined into disks. If cast in the form of rods and lathed or machined into disks, the disks are lathed or machined into IOLs at low temperatures below the glass transition temperature(s) of the material(s). The IOLs, whether molded or machined/lathed, are then cleaned, polished, packaged and sterilized by customary methods known to those skilled in the art.
In addition to IOLs, the polymeric compositions of the present invention are also suitable for use in the manufacture of other ophthalmic devices such as but not limited to contact lenses, keratoprostheses, capsular bag extension rings, corneal inlays, corneal rings or like devices.
IOLs manufactured using the unique polymeric compositions of the present invention are used as customary in the field of ophthalmology. For example, in a surgical procedure, an incision is placed in the cornea of an eye. Most commonly, through the corneal incision the natural lens of the eye is removed (aphakic application) such as in the case of a cataractous natural lens. An IOL is then inserted into the anterior chamber, posterior chamber or lens capsule of the eye prior to closing the incision. However, the subject ophthalmic devices may be used in accordance with other surgical procedures known to those skilled in the field of ophthalmology.
While there is shown and described herein copolymers, polymeric compositions, methods of producing the copolymers and polymeric compositions, methods of producing ophthalmic devices using the polymeric compositions and methods of using ophthalmic devices manufactured from the polymeric compositions, all in accordance with the present invention, it will be manifest to those skilled in the art that various modifications may be made without departing from the spirit and scope of the underlying inventive concept. The present invention is likewise not intended to be limited to particular devices described herein except insofar as indicated by the scope of the appended claims.
Claims (9)
1. Polymeric compositions comprising:
a copolymer of two or more monomers selected from the group consisting of C1-10 alkyl methacrylate, C1-10 alkyl acrylate, C6-4o arylalkyl acrylate and C6-40 arylalkyl methacrylate polymerized with (i) one or more hydrophilic monomers selected from the group consisting of N,N-dimethylacrylamide, glycerol methacrylate, N-vinylpyrrolidinone and 2-hydroxyethyl methacrylate, and (ii) one or more aromatic-based monomers to have a water content greater than 4.5 percent by weight and less than 15 percent by weight, a refractive index of 1.45 or greater and a elongation of 80 percent or greater.
a copolymer of two or more monomers selected from the group consisting of C1-10 alkyl methacrylate, C1-10 alkyl acrylate, C6-4o arylalkyl acrylate and C6-40 arylalkyl methacrylate polymerized with (i) one or more hydrophilic monomers selected from the group consisting of N,N-dimethylacrylamide, glycerol methacrylate, N-vinylpyrrolidinone and 2-hydroxyethyl methacrylate, and (ii) one or more aromatic-based monomers to have a water content greater than 4.5 percent by weight and less than 15 percent by weight, a refractive index of 1.45 or greater and a elongation of 80 percent or greater.
2. The polymeric compositions of claim 1 wherein said aromatic-based monomers are selected from the group consisting of 3,3-diphenylpropyl methacrylate, 3-methacryloyloxypropyl diphenylmethylsilane, 2-(1-naphthylethyl) methacrylate, 3-phenylpropyl acrylate and 2-(2-naphthylethyl) methacrylate.
3. The polymeric compositions of claim 1 further comprising ultraviolet light absorbers.
4. The polymeric compositions of claim 3 wherein said one or more ultraviolet light absorbers are selected from the group consisting of [1-(4-benzotriazoyl-3-hydroxyphenoxy)ethyl acrylate, 4-(2-acryloxyethoxy)-2-hydroxybenzophenone, 4-methacryloyloxy-2-hydroxybenzophenone, 2-(2'-methacryloyloxy-5'-methylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methacryoxyethylphenyl)-2H-benzotriazole, 2-[3'-tert-butyl-2'-hydroxy-5'-(3"-methacryloyloxypropyl)phenyl]-5-chlorobenzotriazole, 2-(3'-tert-butyl-5'-(3"-dimethylvinylsilylpropoxy)-2'-hydroxyphenyl]-5-methoxybenzotriazole, 2-(3'-allyl-2'-hydroxy-5'-methylphenyl)benzotriazole, 2-[3'-tert-butyl-2'-hydroxy-5'-(3"-methacryloyloxypropoxy)phenyl]-5-methoxybenzotriazole, and 2-[3'-tert-butyl-2'-hydroxy-5'-(3"-methacyloyloxypropoxy)phenyl]-5-chlorobenzotriazole.
5. An ophthalmic device comprising a polymer composition of claim 1.
6. A method of producing ophthalmic devices comprising a copolymer of two or more monomers selected from the group consisting of C1-10 alkyl methacrylate, C1-10 alkyl acrylate, C6-40 arylalkyl acrylate and C6-40 arylalkyl methacrylate polymerized with one or more hydrophilic monomers selected from the group consisting of N,N-dimethylacrylamide, glycerol methacrylate, N-vinylpyrrolidinone and 2-hydroxyethyl methacrylate and one or more aromatic-based monomers and hydrophobic monomers, to have a water content greater than 4.5 percent by weight and less than 15 percent by weight, a refractive index of approximately 1.45 or greater and a elongation of 80 percent or greater, the method comprising:
casting one or more polymeric compositions in the form of a rod;
lathing or machining said rod into disks; and lathing or machining said disks into ophthalmic devices.
casting one or more polymeric compositions in the form of a rod;
lathing or machining said rod into disks; and lathing or machining said disks into ophthalmic devices.
7. An ophthalmic device of claim 5 or produced through the method of claim 6 for use in a method comprising:
making an incision in the cornea of an eye; and implanting said ophthalmic device within the eye.
making an incision in the cornea of an eye; and implanting said ophthalmic device within the eye.
8. The method of claim 6 or the ophthalmic device of claim 5 wherein said ophthalmic device is an intraocular lens.
9. The method of claim 6 or the ophthalmic device of claim 5 wherein said ophthalmic device is a corneal inlay.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/175,715 | 2002-06-19 | ||
| US10/175,715 US6852793B2 (en) | 2002-06-19 | 2002-06-19 | Low water content, high refractive index, flexible, polymeric compositions |
| PCT/US2003/018429 WO2004000901A1 (en) | 2002-06-19 | 2003-06-11 | Low water content high refractive index, flexible, polymeric compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2490008A1 CA2490008A1 (en) | 2003-12-31 |
| CA2490008C true CA2490008C (en) | 2010-05-04 |
Family
ID=29733958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2490008A Expired - Fee Related CA2490008C (en) | 2002-06-19 | 2003-06-11 | Low water content high refractive index, flexible, polymeric compositions |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6852793B2 (en) |
| EP (1) | EP1519968A1 (en) |
| JP (1) | JP2005530026A (en) |
| CN (1) | CN100429247C (en) |
| AR (1) | AR040270A1 (en) |
| AU (1) | AU2003243507B2 (en) |
| CA (1) | CA2490008C (en) |
| WO (1) | WO2004000901A1 (en) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7081325B2 (en) * | 2003-06-27 | 2006-07-25 | Hynix Semiconductor Inc. | Photoresist polymer and photoresist composition including the same |
| US7495061B2 (en) * | 2005-05-27 | 2009-02-24 | Bausch + Lomb Incorporated | High refractive-index, hydrophilic monomers and polymers, and ophthalmic devices comprising such polymers |
| ATE503783T1 (en) * | 2005-12-01 | 2011-04-15 | Coronis Gmbh | HIGH REFRACTIVE INDEX POLYMER COMPOSITION |
| US7423108B2 (en) * | 2005-12-16 | 2008-09-09 | Bausch & Lomb Incorporated | High refractive-index siloxy-containing monomers and polymers, and ophthalmic devices comprising such polymers |
| US7759408B2 (en) * | 2005-12-21 | 2010-07-20 | Bausch & Lomb Incorporated | Silicon-containing monomers end-capped with polymerizable cationic hydrophilic groups |
| US7622512B2 (en) * | 2005-12-21 | 2009-11-24 | Bausch & Lomb Incorporated | Cationic hydrophilic siloxanyl monomers |
| US20070161769A1 (en) * | 2006-01-06 | 2007-07-12 | Schorzman Derek A | Polymerizable silicon-containing monomer bearing pendant cationic hydrophilic groups |
| US7960447B2 (en) * | 2006-04-13 | 2011-06-14 | Bausch & Lomb Incorporated | Cationic end-capped siloxane prepolymer for reduced cross-link density |
| PL2026717T3 (en) * | 2006-06-01 | 2013-02-28 | Advanced Vision Science Inc | A non- or reduced glistenings intraocular lens and method of manufacturing same |
| MX2009003813A (en) * | 2006-10-13 | 2009-05-12 | Alcon Inc | Intraocular lenses with unique blue-violet cutoff and blue light transmission characteristics. |
| US20080152540A1 (en) * | 2006-12-22 | 2008-06-26 | Bausch & Lomb Incorporated | Packaging solutions |
| CN101678149B (en) * | 2007-02-21 | 2013-07-17 | 力景公司 | Polymeric materials suitable for ophthalmic devices and methods of manufacture |
| CA2683002C (en) * | 2007-04-30 | 2014-05-20 | Alcon, Inc. | Uv-absorbers for ophthalmic lens materials |
| US7691917B2 (en) | 2007-06-14 | 2010-04-06 | Bausch & Lomb Incorporated | Silcone-containing prepolymers |
| TWI435915B (en) * | 2007-08-09 | 2014-05-01 | Alcon Inc | Ophthalmic lens materials containing chromophores that absorb both uv and short wavelength visible light |
| TW200916531A (en) * | 2007-08-09 | 2009-04-16 | Alcon Inc | Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light |
| US7884228B1 (en) * | 2008-05-06 | 2011-02-08 | Alcon, Inc. | UV-absorbers for ophthalmic lens materials |
| US7803359B1 (en) | 2008-05-06 | 2010-09-28 | Alcon, Inc. | UV-absorbers for ophthalmic lens materials |
| US8043607B2 (en) | 2008-07-15 | 2011-10-25 | Novartis Ag | UV-absorbers for ophthalmic lens materials |
| US8236053B1 (en) | 2008-10-08 | 2012-08-07 | Novartis Ag | 2-amino benzophenone UV-absorbers for ophthalmic lens materials |
| TWI453199B (en) * | 2008-11-04 | 2014-09-21 | Alcon Inc | Uv/visible light absorbers for ophthalmic lens materials |
| DE102008057438A1 (en) * | 2008-11-14 | 2010-05-20 | Evonik Röhm Gmbh | Copolymer for the production of thermally stable moldings from molding compounds or cast glass |
| TWI464151B (en) * | 2009-07-06 | 2014-12-11 | Alcon Inc | Uv/visible light absorbers for ophthalmic lens materials |
| TWI487690B (en) | 2009-07-06 | 2015-06-11 | Alcon Inc | Visible light absorbers for ophthalmic lens materials |
| BR112012005626A2 (en) | 2009-09-15 | 2016-08-02 | Novartis Ag | Suitable prepolymers for making ultraviolet absorption contact lenses |
| TWI473629B (en) | 2010-01-18 | 2015-02-21 | Alcon Inc | Visible light absorbers for ophthalmic lens materials |
| GB201003404D0 (en) | 2010-03-01 | 2010-04-14 | Contamac Ltd | High refractive index polymer composition for opthalmic applications |
| AU2011245400B2 (en) | 2010-04-29 | 2015-01-29 | Alcon Inc. | Intraocular lenses with combinations of UV absorbers and blue light chromophores |
| JP5784119B2 (en) | 2010-07-30 | 2015-09-24 | ノバルティス アーゲー | Amphiphilic polysiloxane prepolymers and their use |
| US8835525B2 (en) | 2010-10-06 | 2014-09-16 | Novartis Ag | Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains |
| EP2625218B1 (en) | 2010-10-06 | 2018-04-25 | Novartis AG | Water-processable silicone-containing prepolymers and uses thereof |
| WO2012047961A1 (en) | 2010-10-06 | 2012-04-12 | Novartis Ag | Polymerizable chain-extended polysiloxanes with pendant hydrophilic groups |
| TW201311621A (en) | 2011-08-15 | 2013-03-16 | Novartis Ag | UV-absorbers for ophthalmic lens materials |
| US8585938B1 (en) | 2012-03-30 | 2013-11-19 | Novartis Ag | UV-absorbers for ophthalmic lens materials |
| CN104395387A (en) | 2012-06-26 | 2015-03-04 | 诺华股份有限公司 | 2-amino benzophenone UV-absorbers for ophthalmic lens materials |
| WO2014106866A1 (en) * | 2013-01-07 | 2014-07-10 | Council Of Scientific & Industrial Research | Flexible, high refractive index hydrophobic copolymer |
| KR101715672B1 (en) * | 2013-02-28 | 2017-03-13 | 쇼와 덴코 가부시키가이샤 | Curable composition, transparent heat-resistant material, and use thereof |
| CN106999628A (en) * | 2014-12-16 | 2017-08-01 | 诺华股份有限公司 | Hydrophobic acrylic acid's ester acrylamide copolymer for Ophthalmoligic instrument |
| JP6371480B2 (en) * | 2014-12-16 | 2018-08-08 | ノバルティス アーゲー | Low water content acrylate-acrylamide copolymers for ophthalmic appliances |
| WO2016133656A1 (en) | 2015-02-16 | 2016-08-25 | Novartis Ag | Wet-pack intraocular lens materials with high refractive index |
| AU2016275073B2 (en) * | 2015-06-10 | 2021-02-25 | Alcon Inc. | Intraocular lens materials and components |
| KR101835941B1 (en) * | 2015-10-19 | 2018-03-08 | 삼성에스디아이 주식회사 | Composition for encapsulating organic light emitting diode device and organic light emitting diode display using prepared the same |
| CN106632898A (en) * | 2015-11-04 | 2017-05-10 | 鸿富锦精密工业（深圳）有限公司 | Spectacle lens material, and spectacle lens and preparation method thereof |
| CN106729975B (en) | 2015-11-19 | 2020-04-14 | 爱博诺德(北京)医疗科技股份有限公司 | Material for producing artificial lens |
| CN107641168B (en) * | 2016-07-20 | 2021-09-28 | 东莞东阳光医疗智能器件研发有限公司 | Polymer, preparation method and application thereof |
| EP3363794A1 (en) * | 2017-02-15 | 2018-08-22 | Merck Patent GmbH | Bis-compounds for optically active devices |
| RU2728693C1 (en) * | 2017-06-05 | 2020-07-31 | Алькон Инк. | Materials for intraocular lens with high refraction index and high abbe number |
| US11781040B2 (en) | 2017-08-31 | 2023-10-10 | Samsung Sdi Co., Ltd. | Adhesive film and optical member comprising same |
| CN110003384B (en) * | 2018-01-05 | 2022-02-15 | 东莞东阳光医疗智能器件研发有限公司 | Polymer, preparation method and application thereof |
| US11583389B2 (en) | 2019-04-05 | 2023-02-21 | Amo Groningen B.V. | Systems and methods for correcting photic phenomenon from an intraocular lens and using refractive index writing |
| US11583388B2 (en) | 2019-04-05 | 2023-02-21 | Amo Groningen B.V. | Systems and methods for spectacle independence using refractive index writing with an intraocular lens |
| US11944574B2 (en) | 2019-04-05 | 2024-04-02 | Amo Groningen B.V. | Systems and methods for multiple layer intraocular lens and using refractive index writing |
| US11678975B2 (en) | 2019-04-05 | 2023-06-20 | Amo Groningen B.V. | Systems and methods for treating ocular disease with an intraocular lens and refractive index writing |
| US11564839B2 (en) | 2019-04-05 | 2023-01-31 | Amo Groningen B.V. | Systems and methods for vergence matching of an intraocular lens with refractive index writing |
| US11529230B2 (en) | 2019-04-05 | 2022-12-20 | Amo Groningen B.V. | Systems and methods for correcting power of an intraocular lens using refractive index writing |
| US11708440B2 (en) | 2019-05-03 | 2023-07-25 | Johnson & Johnson Surgical Vision, Inc. | High refractive index, high Abbe compositions |
| EP3962411A4 (en) | 2019-05-03 | 2023-01-25 | Johnson & Johnson Surgical Vision, Inc. | High reactive index, high abbe compositions |
| KR102430601B1 (en) | 2020-03-03 | 2022-08-08 | 삼성에스디아이 주식회사 | Adhesive film, optical member comprising the same and optical display apparatus comprising the same |
| JP2023547481A (en) | 2020-10-29 | 2023-11-10 | ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド | Compositions with high refractive index and Abbe number |
| CN113527567B (en) * | 2021-07-26 | 2023-01-24 | 康小林 | Hydrophobic non-glare high refractive index ophthalmic polymeric materials |
| CN114874403B (en) * | 2022-06-02 | 2023-07-07 | 香港中文大学（深圳） | Organogel, method for preparing the same, and transparent optical device |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3996187A (en) | 1975-04-29 | 1976-12-07 | American Optical Corporation | Optically clear filled silicone elastomers |
| US3996189A (en) | 1975-04-29 | 1976-12-07 | American Optical Corporation | Optically clear filled silicone elastomers |
| US4190693A (en) * | 1975-06-17 | 1980-02-26 | Rohm And Haas Company | Coating method using compositions comprising acrylic oligomers, high polymers and crosslinkers |
| US4418165A (en) | 1980-06-03 | 1983-11-29 | Dow Corning Corporation | Optically clear silicone compositions curable to elastomers |
| US4647282A (en) | 1985-08-27 | 1987-03-03 | Moskovsky Nauchno-Issledovatelsky Institut Mikrokhirurgii Glaza | Material for ocular prosthetics |
| US4868251A (en) | 1986-12-24 | 1989-09-19 | Allergan, Inc. | Ultraviolet light absorbing silicone compositions |
| US5512609A (en) | 1992-04-14 | 1996-04-30 | Allergan, Inc. | Reinforced compositions and lens bodies made from same |
| US6277940B1 (en) * | 1997-08-20 | 2001-08-21 | Menicon Co. Ltd | Material for a soft intraocular lens |
| US6326448B1 (en) | 1997-08-20 | 2001-12-04 | Menicon Co., Ltd. | Soft intraocular lens material |
| CN1213671A (en) * | 1997-10-07 | 1999-04-14 | 参天制药株式会社 | Four-component copolymer and eye lens formed by same |
| US6245106B1 (en) * | 1998-10-29 | 2001-06-12 | Allergan Sales, Inc. | Intraocular lenses made from polymeric compositions and monomers useful in said compositions |
| ATE270611T1 (en) | 2000-04-21 | 2004-07-15 | Advanced Medical Optics Inc | METHOD FOR PRODUCING AN ACCOMMODATING INTRAOCULAR LENS |
| US6555030B1 (en) * | 2000-04-21 | 2003-04-29 | Advanced Medical Optics, Inc. | Method for making an accommodating intraocular lens |
-
2002
- 2002-06-19 US US10/175,715 patent/US6852793B2/en not_active Expired - Lifetime
-
2003
- 2003-06-11 JP JP2004515774A patent/JP2005530026A/en active Pending
- 2003-06-11 EP EP03761053A patent/EP1519968A1/en not_active Withdrawn
- 2003-06-11 WO PCT/US2003/018429 patent/WO2004000901A1/en active Application Filing
- 2003-06-11 CN CNB038144697A patent/CN100429247C/en not_active Expired - Fee Related
- 2003-06-11 CA CA2490008A patent/CA2490008C/en not_active Expired - Fee Related
- 2003-06-11 AU AU2003243507A patent/AU2003243507B2/en not_active Ceased
- 2003-06-18 AR ARP030102168A patent/AR040270A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1519968A1 (en) | 2005-04-06 |
| CN100429247C (en) | 2008-10-29 |
| AU2003243507A1 (en) | 2004-01-06 |
| WO2004000901A1 (en) | 2003-12-31 |
| CN1662568A (en) | 2005-08-31 |
| JP2005530026A (en) | 2005-10-06 |
| US6852793B2 (en) | 2005-02-08 |
| US20030236375A1 (en) | 2003-12-25 |
| AR040270A1 (en) | 2005-03-23 |
| AU2003243507B2 (en) | 2008-10-16 |
| CA2490008A1 (en) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2490008C (en) | Low water content high refractive index, flexible, polymeric compositions | |
| AU2002337880B2 (en) | High refractive index polymeric siloxysilane compositions | |
| US7138440B2 (en) | High refractive index polymeric siloxysilane compositions | |
| US6657030B2 (en) | High refractive index hydrogel compositions for ophthalmic implants | |
| US6881809B2 (en) | High refractive index aromatic-based silyl monomers | |
| US20040054026A1 (en) | Elastomeric, expandable hydrogel compositions | |
| AU2002337880A1 (en) | High refractive index polymeric siloxysilane compositions | |
| WO2000079312A1 (en) | High refractive index compositions for ophthalmic implants | |
| KR20050023312A (en) | Low water content high refractive index, flexible, polymeric compositions | |
| AU2002348475A1 (en) | High refractive index polymeric siloxysilane compositions | |
| AU2002351482A1 (en) | High Refractive Index Aromatic-based Silyl Monomers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20210611 |
|
| MKLA | Lapsed |
Effective date: 20210611 |